Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes

References

• KahnSECooperMEDel PratoSPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and futureLancet201438399221068108324315620
   PubMed Web of Science ®Google Scholar
• International Diabetes FederationIDF Diabetes Atlas6th ed2013 Available from: https://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdfAccessed December 5, 2016
   Google Scholar
• GroupUKHSRisk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their durationDiabetologia20075061140114717415551
   PubMed Web of Science ®Google Scholar
• Canadian Diabetes Association Clinical Practice Guidelines Expert CClaytonDWooVYaleJFHypoglycemiaCan J Diabetes201337suppl 1S69S7124070966
   PubMed Web of Science ®Google Scholar
• SeaquistERAndersonJChildsBHypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine SocietyDiabetes Care20133651384139523589542
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyGuideline on Clinical Investigation of Medicinal Products in the Treatment or Prevention of Diabetes Mellitus2012 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129256.pdfAccessed December 5, 2016
   Google Scholar
• ZammittNNFrierBMHypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalitiesDiabetes Care200528122948296116306561
   PubMed Web of Science ®Google Scholar
• FrierBMHypoglycaemia in diabetes mellitus: epidemiology and clinical implicationsNat Rev Endocrinol2014101271172225287289
   PubMed Web of Science ®Google Scholar
• DaviesMJThawarePKTringhamJRA randomized controlled trial examining combinations of repaglinide, metformin and NPH insulinDiabet Med200724771471917403126
   PubMed Web of Science ®Google Scholar
• DiamantMVan GaalLStranksSSafety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeksDiabetes Care201235468368922357185
   PubMed Web of Science ®Google Scholar
• EspositoKCiotolaMMaiorinoMIAddition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trialAnn Intern Med2008149853153918936501
   PubMed Web of Science ®Google Scholar
• RaskinPRHollanderPALewinAINITIATE Study GroupBasal insulin or premix analogue therapy in type 2 diabetes patientsEur J Intern Med2007181566217223044
   PubMed Web of Science ®Google Scholar
• RosenstockJSugimotoDStrangePStewartJASoltes-RakEDaileyGTriple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patientsDiabetes Care200629355455916505505
   PubMed Web of Science ®Google Scholar
• RossSAZinmanBCamposRVStrackTCanadian Lispro Study GroupA comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agentsClin Invest Med200124629229811767232
   PubMed Web of Science ®Google Scholar
• DeFronzoRARatnerREHanJKimDDFinemanMSBaronADEffects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetesDiabetes Care20052851092110015855572
   PubMed Web of Science ®Google Scholar
• MarreMHowlettHLehertPAllavoineTImproved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in type 2 diabetic patients inadequately controlled on metforminDiabet Med200219867368012147149
   PubMed Web of Science ®Google Scholar
• BergenstalRMWyshamCMacconellLEfficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trialLancet2010376973943143920580422
   PubMed Web of Science ®Google Scholar
• AschnerPChanJOwensDRInsulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trialLancet201237998332262226922683131
   PubMed Web of Science ®Google Scholar
• BarnettAHBurgerJJohnsDTolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trialClin Ther200729112333234818158075
   PubMed Web of Science ®Google Scholar
• ChoYMKooBKSonHYEffect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitusJ Diabetes Investig201014143148
   Web of Science ®Google Scholar
• GaoYYoonKHChuangLMEfficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylureaDiabetes Res Clin Pract2009831697619019476
   PubMed Web of Science ®Google Scholar
• HeineRJVan GaalLFJohnsDGWAA Study GroupExenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trialAnn Intern Med2005143855956916230722
   PubMed Web of Science ®Google Scholar
• JankaHUPleweGRiddleMCKliebe-FrischCSchweitzerMAYki-JarvinenHComparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetesDiabetes Care200528225425915677775
   PubMed Web of Science ®Google Scholar
• NauckMAEllisGCFleckPRWilsonCAMekkiQAlogliptin Study 008 GroupEfficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled studyInt J Clin Pract2009631465519125992
   PubMed Web of Science ®Google Scholar
• Yki-JarvinenHKauppinen-MakelinRTiikkainenMInsulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET studyDiabetologia200649344245116456680
   PubMed Web of Science ®Google Scholar